294 related articles for article (PubMed ID: 26593333)
41. Generator replacement is associated with an increased rate of ICD lead alerts.
Lovelock JD; Cruz C; Hoskins MH; Jones P; El-Chami MF; Lloyd MS; Leon A; DeLurgio DB; Langberg JJ
Heart Rhythm; 2014 Oct; 11(10):1785-9. PubMed ID: 24953380
[TBL] [Abstract][Full Text] [Related]
42. Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures.
Resnic FS; Majithia A; Dhruva SS; Ssemaganda H; Robbins S; Marinac-Dabic D; Hewitt K; Ohno-Machado L; Reynolds MR; Matheny ME
Circ Cardiovasc Qual Outcomes; 2020 Apr; 13(4):e006105. PubMed ID: 32283971
[TBL] [Abstract][Full Text] [Related]
43. Predictors of pacemaker dependence and pacemaker dependence as a predictor of mortality in patients with implantable cardioverter defibrillator.
Sood N; Crespo E; Friedman M; Guertin D; Zweibel S; Kluger J; Clyne CA
Pacing Clin Electrophysiol; 2013 Aug; 36(8):945-51. PubMed ID: 23668483
[TBL] [Abstract][Full Text] [Related]
44. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
[TBL] [Abstract][Full Text] [Related]
45. Association between socioeconomic factors and ICD implantation in a publicly financed health care system: a Danish nationwide study.
Winther-Jensen M; Hassager C; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Christensen EF; Kragholm K; Kjaergaard J
Europace; 2018 Jul; 20(7):1129-1137. PubMed ID: 29016817
[TBL] [Abstract][Full Text] [Related]
46. Implantable cardioverter-defibrillator lead failure: how weak is the link?
Brinker JA
Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
[TBL] [Abstract][Full Text] [Related]
47. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
[TBL] [Abstract][Full Text] [Related]
48. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients.
Robin J; Weinberg K; Tiongson J; Carnethon M; Reddy M; Ciaccio C; Quadrini M; Hsu J; Fan J; Choi P; Kadish A; Goldberger J; Passman R
Heart Rhythm; 2006 Oct; 3(10):1196-201. PubMed ID: 17018351
[TBL] [Abstract][Full Text] [Related]
49. High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?
Osswald BR; De Simone R; Most S; Tochtermann U; Tanzeem A; Karck M
Eur J Cardiothorac Surg; 2009 Mar; 35(3):489-92. PubMed ID: 19144533
[TBL] [Abstract][Full Text] [Related]
50. Prospective long-term evaluation of Optim-insulated (Riata ST Optim and Durata) implantable cardioverter-defibrillator leads.
Cairns JA; Epstein AE; Rickard J; Connolly SJ; Buller C; Wilkoff BL; Pogue J; Themeles E; Healey JS
Heart Rhythm; 2014 Dec; 11(12):2156-62. PubMed ID: 25131665
[TBL] [Abstract][Full Text] [Related]
51. Predictors of successful defibrillation threshold test during CRT-D implantation.
Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F
Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010
[TBL] [Abstract][Full Text] [Related]
52. Implantable intravascular defibrillator: defibrillation thresholds of an intravascular cardioverter-defibrillator compared with those of a conventional ICD in humans.
Neuzil P; Reddy VY; Merkely B; Geller L; Molnar L; Bednarek J; Bartus K; Richey M; Bsee TJ; Sanders WE
Heart Rhythm; 2014 Feb; 11(2):210-5. PubMed ID: 24144885
[TBL] [Abstract][Full Text] [Related]
53. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
54. Nomogram for predicting 30-day all-cause mortality after transvenous pacemaker and defibrillator lead extraction.
Brunner MP; Yu C; Hussein AA; Tarakji KG; Wazni OM; Kattan MW; Wilkoff BL
Heart Rhythm; 2015 Dec; 12(12):2381-6. PubMed ID: 26190318
[TBL] [Abstract][Full Text] [Related]
55. Long-Term Evaluation of Biotronik Linox and Linox(smart) Implantable Cardioverter Defibrillator Leads.
Good ED; Cakulev I; Orlov MV; Hirsh D; Simeles J; Mohr K; Moll P; Bloom H
J Cardiovasc Electrophysiol; 2016 Jun; 27(6):735-42. PubMed ID: 26990515
[TBL] [Abstract][Full Text] [Related]
56. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
[TBL] [Abstract][Full Text] [Related]
57. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.
Ruwald MH; Zareba W; Jons C; Zhang C; Ruwald AC; Olshansky B; McNitt S; Bloch Thomsen PE; Shoda M; Merkely B; Moss AJ; Kutyifa V
Circulation; 2013 Aug; 128(7):694-701. PubMed ID: 23881862
[TBL] [Abstract][Full Text] [Related]
58. Internal insulation breaches in an implantable cardioverter-defibrillator lead with redundant conductors.
Hauser RG; Sengupta J; Schloss EJ; Stanberry LI; Wananu MK; Abdelhadi R
Heart Rhythm; 2019 Aug; 16(8):1215-1222. PubMed ID: 30772531
[TBL] [Abstract][Full Text] [Related]
59. Validation of defibrillator lead performance registry data: insight from the Danish Pacemaker and ICD Register.
Kristensen AE; Larsen JM; Nielsen JC; Johansen JB; Haarbo J; Petersen HH; Riahi S
Europace; 2017 Jul; 19(7):1187-1192. PubMed ID: 27738061
[TBL] [Abstract][Full Text] [Related]
60. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.
Ellis CR; Rottman JN
Heart Rhythm; 2009 May; 6(5):619-24. PubMed ID: 19389648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
